Bias Against People Who Inject Drugs Undermines Police Training on Needlestick Injury

per Davis, Corey S.
Publicat a Am J Public Health (2019)

Bundling occupational safety with harm reduction information as a feasible method for improving police receptiveness to syringe access programs: evidence from three U.S. cities

per Davis, Corey S, Beletsky, Leo
Publicat 2009

Opportunities to Improve Decision-Making About Opioid Prescribing

per Rutkow, Lainie, Davis, Corey S.
Publicat a J Gen Intern Med (2016)

Opioid Policy Changes During the COVID-19 Pandemic - and Beyond

per Davis, Corey S., Samuels, Elizabeth A.
Publicat a J Addict Med (2020)

Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19

per Davis, Corey S., Samuels, Elizabeth A.
Publicat a Int J Drug Policy (2021)

Chapter 18 Preserving Digital Humanities Projects Using Principles of Digital Longevity

per Huculak, J. Matthew, Davis, Corey
Publicat 2025

Evolution and Convergence of State Laws Governing Controlled Substance Prescription Monitoring Programs, 1998-2011

per Davis, Corey S., Pierce, Matthew, Dasgupta, Nabarun
Publicat 2014

Reducing Harm Through Litigation Against Opioid Manufacturers? Lessons From the Tobacco Wars

per Carr, Derek, Davis, Corey S., Rutkow, Lainie
Publicat a Public Health Rep (2018)

Yes, You Need a Lawyer: Integrating Legal Epidemiology Into Health Research

per Hoss, Aila, Davis, Corey S., Burris, Scott
Publicat a Public Health Rep (2020)

Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States

per Smart, Rosanna, Pardo, Bryce, Davis, Corey S.
Publicat a Addiction (2020)

The Law (and Politics) of Safe Injection Facilities in the United States

per Beletsky, Leo, Davis, Corey S., Anderson, Evan, Burris, Scott
Publicat 2008

Overdose Epidemic, Prescription Monitoring Programs, and Public Health: A Review of State Laws

per Davis, Corey S., Johnston, Jill E., Pierce, Matthew W.
Publicat a Am J Public Health (2015)

Co-prescribing naloxone does not increase liability risk

per Davis, Corey S., Burris, Scott, Beletsky, Leo, Binswanger, Ingrid
Publicat a Subst Abus (2016)

Paraphernalia Laws, Criminalizing Possession and Distribution of Items Used to Consume Illicit Drugs, and Injection-Related Harm

per Davis, Corey S., Carr, Derek H., Samuels, Elizabeth A.
Publicat a Am J Public Health (2019)

Opioid Litigation and Maternal-Child Health–Investing in the Future

per Patrick, Stephen W., Davis, Corey S., Stein, Bradley D.
Publicat a JAMA Pediatr (2020)

Considering the Potential Benefits of Over-the-Counter Naloxone

per Evoy, Kirk E, Hill, Lucas G, Davis, Corey S
Publicat a Integr Pharm Res Pract (2021)

Reply to Letter to the Editor Regarding Article: “Considering the Potential Benefits of Over-The-Counter Naloxone” [Response To Letter]

per Evoy, Kirk E, Hill, Lucas G, Davis, Corey S
Publicat a Integr Pharm Res Pract (2021)

Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration

per Davis, Corey S., Carr, Derek, Southwell, Jessica K., Beletsky, Leo
Publicat a Am J Public Health (2015)

Association between medical cannabis laws and opioid overdose mortality has reversed over time

per Shover, Chelsea L., Davis, Corey S., Gordon, Sanford C., Humphreys, Keith
Publicat a Proc Natl Acad Sci U S A (2019)

Opioid Prescribing Laws Are Not Associated with Short-term Declines in Prescription Opioid Distribution

per Davis, Corey S, Piper, Brian J, Gertner, Alex K, Rotter, Jason S
Publicat a Pain Med (2020)